HRT FINANCIAL LP

Position in MYGN — Myriad Genetics Inc

CIK 1475597 NEW YORK, NY

Position in MYGN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$8,038,435

+$5,154,897 QoQ

Shares Held

1,786,319

+281.0% QoQ

Ownership

1.89%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $56,167,229 across 14 Diagnostics & Research names. MYGN ranks #2 (14.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DHR	Danaher Corp /De/	177,683	$33,688,696
2	MYGN	Myriad Genetics Inc This page	1,786,319	$8,038,435
3	MEDP	Medpace Holdings, Inc.	7,571	$3,635,518
4	QGEN	Qiagen N.V.	72,302	$2,894,972
5	SHC	Sotera Health Co	139,192	$1,996,013
6	ADPT	Adaptive Biotechnologies Corp	131,241	$1,821,625
7	PSNL	Personalis, Inc.	208,891	$1,330,635
8	VCYT	Veracyte, Inc.	31,312	$1,008,559

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,038,435	1,786,319	+281.0%	Shares	Defined	2026-05-14
2025-12-31	$2,883,538	468,868	-40.7%	Shares	Defined	2026-02-12
2025-09-30	$5,715,813	790,569	+465.1%	Shares	Defined	2025-11-14
2025-06-30	$742,869	139,900	+530.4%	Shares	Defined	2025-08-14
2024-09-30	$607,866	22,193	-68.5%	Shares	Defined	2024-11-12
2023-09-30	$1,130,370	70,472	-31.8%	Shares	Defined	2023-11-13
2023-03-31	$2,399,868	103,309	+176.3%	Shares	Defined	2023-05-12
2022-12-31	$542,572	37,393	-10.6%	Shares	Defined	2023-02-10
2022-03-31	$1,053,687	41,813	+48.1%	Shares	Defined	2022-05-16
2020-12-31	$558,047	28,227	-27.7%	Shares	Defined	2021-02-16
2020-09-30	$508,872	39,024	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.